Clinical Trials Insight: 700046954
Phase of Trial: Phase I
Latest Information Update: 17 Jul 2009
At a glance
- Drugs NI 0801 (Primary)
- Indications Allotransplant rejection; Atherosclerosis; Coeliac disease; Hepatic fibrosis; Inflammation; Lupus vulgaris; Multiple sclerosis; Myasthenia gravis; Nephritis; Psoriasis; Pulmonary fibrosis; Rheumatoid arthritis; Systemic lupus erythematosus; Type 1 diabetes mellitus; Ulcerative colitis
- Focus Adverse reactions
- Sponsors NovImmune SA
- 17 Jul 2009 New trial record.
- 13 Jul 2009 Results have been announced in a NovImmune media release.